share_log

济川药业(600566.SH):子公司获得药品注册证书

Hubei Jumpcan Pharmaceutical (600566.SH): Subsidiary obtained the Pharmaceutical registration certificate.

Gelonghui Finance ·  Dec 12 17:15

On December 12, Gelonghui reported that Hubei Jumpcan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary, Hubei Jumpcan Pharmaceutical Group Co., Ltd., and Shaanxi Dongke Pharmaceutical Co., Ltd. received the drug registration certificates from the National Medical Products Administration for Pediatric Faropenem Sodium Granules and Cefoperazone Sodium for Injection. The registration classification of Pediatric Faropenem Sodium Granules is Chemical Drug Class 4, evaluated and approved according to the technical requirements consistent with the quality and efficacy of the reference preparation, and is regarded as passing the consistency evaluation of generic drug quality and efficacy after approval, mainly used for the treatment of infectious diseases in children caused by bacteria sensitive to Faropenem. The registration classification of Cefoperazone Sodium for Injection is Chemical Drug Class 4, evaluated and approved according to the technical requirements consistent with the quality and efficacy of the reference preparation, and is regarded as passing the consistency evaluation of generic drug quality and efficacy after approval, mainly used for lower respiratory tract infections, urinary tract infections, abdominal infections, pelvic infections, sepsis, skin and soft tissue infections, bone and joint infections, meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, and uncomplicated gonorrhea caused by sensitive bacteria.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment